Skip to content
The Institute for Exposomic Research

The Institute for Exposomic Research

Uncovering how environmental exposures shape human health

  • Institute
    • About
    • Meet Our Team
    • Director’s Blog
    • Newsroom
    • Labs
    • Publications
    • Black Child Health Working Group
    • Dept. of Envi Med & Public Health
    • HEALS
    • Contact Us
  • Research
    • Featured Studies
    • Child Health
    • Pregnancy
    • Cancer
    • Asthma
    • Autism
    • Cardiovascular Health
    • ALS
    • Nutrition
    • Parkinson’s Disease
    • COVID-19
    • Social Environment
    • Air Pollution
  • Events
    • Lunchtime Chats
    • 2023 USA – European Exposome Symposium
    • 2023 USA – Mexico City Exposome Symposium
    • Clinical Climate Change
  • Partnerships
    • CUNY
    • NYSCHECK
    • PEHSU
    • The Partnership for Healthy Playing Surfaces
    • Safe & Just Cleaners
  • Get Involved
    • Get Updates
    • Support Our Research
    • Ask A Question
  • Learning Hub
  • Facebook
  • Twitter
  • Instagram
Home » Paul Curtin

Tag: Paul Curtin

In the News

New Theory Sheds Light on How the Environment Influences Human Health

In a new book, Dr. Manish Arora and Dr. Paul Curtin of the Mount Sinai Institute for Exposomic Research suggest that a newly proposed component—the biodynamic interface—may better explain how humans interact with their environment

by sinaiexposomicsJanuary 19, 2022January 19, 2022
Continue Reading
Autism In the News

Mount Sinai Spin-Off Company, Linus Biotechnology Inc., Receives FDA Breakthrough Device Designation for its ASD Diagnostic Product

StrandDx™- ASD Exposome Sequencing Diagnostic was developed based on technology developed by researchers in the  Institute for Exposomic Research at Mount Sinai.

by sinaiexposomicsDecember 8, 2021October 14, 2022
Continue Reading
Autism In the News

Mount Sinai Spin-Off Company, Linus Biotechnology Inc., to Revolutionize Precision Medicine with Exposome Sequencing

Subject to regulatory approvals, the new company intends to launch its first product with StrandDx™- ASD a molecular biomarker for autism spectrum disorder that can be applied at birth, and can assist in early Autism Spectrum Disorder diagnosis.

by sinaiexposomicsNovember 18, 2021
Continue Reading

The Institute for Exposomic Research

Uncovering how environmental exposures shape human health

  • Facebook
  • Twitter
  • Instagram
  • Contact Us
  • Donate
  • Privacy Policy
  • Terms and Conditions
  • Non-Discrimination Notice